scholarly journals Long‐term course of bronchial inflammation and pulmonary function testing in children with post‐infectious bronchiolitis obliterans

2021 ◽  
Author(s):  
Silvija Pera Jerkic ◽  
Sinem Koc‐Günel ◽  
Eva Herrmann ◽  
Lia Kriszeleit ◽  
Jonas Eckrich ◽  
...  
Keyword(s):  
Pulmonary Function ◽  
Bronchiolitis Obliterans ◽  
Pulmonary Function Testing ◽  
Bronchial Inflammation ◽  
Function Testing ◽  
Post Infectious

scholarly journals Long‐term pulmonary function testing in pediatric bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation

2020 ◽  
Vol 55 (7) ◽  
pp. 1725-1735 ◽  
Author(s):  
Sophie Walther ◽  
Eva Rettinger ◽  
Hannah Miriam Maurer ◽  
Helena Pommerening ◽  
Andrea Jarisch ◽  
...  
Keyword(s):  
Stem Cell ◽  
Hematopoietic Stem Cell Transplantation ◽  
Stem Cell Transplantation ◽  
Pulmonary Function ◽  
Bronchiolitis Obliterans ◽  
Bronchiolitis Obliterans Syndrome ◽  
Pulmonary Function Testing ◽  
Hematopoietic Stem ◽  
Function Testing

Benign Tracheobronchial Stenoses: Changes in Short-Term and Long-Term Pulmonary Function Testing After Expandable Metallic Stent Placement

2002 ◽  
Vol 26 (4) ◽  
pp. 564-572 ◽  
Author(s):  
Michael B. Gotway ◽  
Jeffrey A. Golden ◽  
Jeanne M. LaBerge ◽  
W. Richard Webb ◽  
Gautham P. Reddy ◽  
...  
Keyword(s):  
Pulmonary Function ◽  
Stent Placement ◽  
Pulmonary Function Testing ◽  
Metallic Stent ◽  
Short Term ◽  
Expandable Metallic Stent ◽  
Function Testing ◽  
Metallic Stent Placement

COPD – Stellenwert der Lungenfunktionsanalyse in Diagnostik und Therapie

2018 ◽  
Vol 143 (08) ◽  
pp. 593-596 ◽  
Author(s):  
Wolfram Windisch ◽  
Carl Criée
Keyword(s):  
Pulmonary Function ◽  
Airway Obstruction ◽  
Pulmonary Emphysema ◽  
Pulmonary Function Testing ◽  
Exclusion Criterion ◽  
Chronic Obstructive ◽  
Pharmaceutical Treatment ◽  
Lung Hyperinflation ◽  
Function Testing

AbstractPulmonary function testing is essential for diagnosis and treatment-guidance of chronic obstructive pulmonary disease (COPD). Airway obstruction as assessed by spirometry should follow the reference-values provided by the Global Lung Initiative (GLI) of the European Respiratory Society (ERS). In addition, lung function testing should also include the assessment of lung hyperinflation and pulmonary emphysema by full-body plethysmography and determination of diffusion capacity. This is important since both, lung hyperinflation and pulmonary emphysema, can present without existing airway obstruction. Even though this formally excludes the diagnosis of COPD, these entities still belong to this disease complex. However, strictly speaking, pharmaceutical treatment is valid only for those patients with co-existing airway obstruction according to Global Lung Initiative for Chronic Obstructive Lung Disease (GOLD) criteria – since the absence of airway obstruction serves as exclusion criterion in nearly all randomized controlled trials. Nevertheless, progressive symptoms still require detailed pulmonary function testing for the guidance of non-pharmaceutical treatment – such as endoscopic or surgical lung volume reduction, long-term oxygen therapy, long-term non-invasive ventilation, and lung transplantation.

Longitudinal pulmonary function testing outcome measures in Duchenne muscular dystrophy: long-term natural history with and without glucocorticoids

2017 ◽  
Vol 27 ◽  
pp. S115-S116 ◽  
Author(s):  
C. McDonald ◽  
H. Gordish-Dressman ◽  
E. Henricson ◽  
T. Duong ◽  
N. Joyce ◽  
...  
Keyword(s):  
Duchenne Muscular Dystrophy ◽  
Muscular Dystrophy ◽  
Natural History ◽  
Pulmonary Function ◽  
Outcome Measures ◽  
Pulmonary Function Testing ◽  
Function Testing

scholarly journals Longitudinal pulmonary function testing outcome measures in Duchenne muscular dystrophy: Long-term natural history with and without glucocorticoids

2018 ◽  
Vol 28 (11) ◽  
pp. 897-909 ◽  
Author(s):  
Craig M. McDonald ◽  
Heather Gordish-Dressman ◽  
Erik K. Henricson ◽  
Tina Duong ◽  
Nanette C. Joyce ◽  
...  
Keyword(s):  
Duchenne Muscular Dystrophy ◽  
Muscular Dystrophy ◽  
Natural History ◽  
Pulmonary Function ◽  
Outcome Measures ◽  
Pulmonary Function Testing ◽  
Function Testing

Exercise and Pulmonary Function Testing in Patients in Long-Term Remission of Wilms Nephroblastoma.

2009 ◽  
Author(s):  
J Sulc ◽  
J Radvanska ◽  
J Radvansky ◽  
K Slaby ◽  
M Safarova ◽  
...  
Keyword(s):  
Pulmonary Function ◽  
Pulmonary Function Testing ◽  
Function Testing

Specifications for equipment used for infant pulmonary function testing

2000 ◽  
Vol 16 (4) ◽  
pp. 731 ◽  
Author(s):  
U. Frey ◽  
J. Stocks ◽  
A Coates ◽  
P Sly ◽  
J Bates ◽  
...  
Keyword(s):  
Pulmonary Function ◽  
Pulmonary Function Testing ◽  
Function Testing ◽  
Infant Pulmonary Function ◽  
Infant Pulmonary Function Testing

scholarly journals Pulmonary Function Testing in Work-Related Asthma: An Overview from Spirometry to Specific Inhalation Challenge

2021 ◽  
Vol 18 (5) ◽  
pp. 2325
Author(s):  
Mathias Poussel ◽  
Isabelle Thaon ◽  
Emmanuelle Penven ◽  
Angelica I. Tiotiu
Keyword(s):  
Pulmonary Function ◽  
Pulmonary Function Tests ◽  
Objective Evaluation ◽  
Pulmonary Function Testing ◽  
Initial Assessment ◽  
Work Related ◽  
Specific Inhalation Challenge ◽  
Occupational Setting ◽  
Inhalation Challenge ◽  
Function Testing

Work-related asthma (WRA) is a very frequent condition in the occupational setting, and refers either to asthma induced (occupational asthma, OA) or worsened (work-exacerbated asthma, WEA) by exposure to allergens (or other sensitizing agents) or to irritant agents at work. Diagnosis of WRA is frequently missed and should take into account clinical features and objective evaluation of lung function. The aim of this overview on pulmonary function testing in the field of WRA is to summarize the different available tests that should be considered in order to accurately diagnose WRA. When WRA is suspected, initial assessment should be carried out with spirometry and bronchodilator responsiveness testing coupled with first-step bronchial provocation testing to assess non-specific bronchial hyper-responsiveness (NSBHR). Further investigations should then refer to specialists with specific functional respiratory tests aiming to consolidate WRA diagnosis and helping to differentiate OA from WEA. Serial peak expiratory flow (PEF) with calculation of the occupation asthma system (OASYS) score as well as serial NSBHR challenge during the working period compared to the off work period are highly informative in the management of WRA. Finally, specific inhalation challenge (SIC) is considered as the reference standard and represents the best way to confirm the specific cause of WRA. Overall, clinicians should be aware that all pulmonary function tests should be standardized in accordance with current guidelines.

Pulmonary Function Testing in Patients with Tracheostomies: Feasibility and Technical Considerations

Lung ◽  
2021 ◽  
Author(s):  
Ajay Sheshadri ◽  
Leendert Keus ◽  
David Blanco ◽  
Xiudong Lei ◽  
Cheryl Kellner ◽  
...  
Keyword(s):  
Pulmonary Function ◽  
Pulmonary Function Testing ◽  
Function Testing ◽  
Technical Considerations
Sign in / Sign up

Export Citation Format

Share Document